Ying Wang

Orcid: 0000-0003-0296-7402

Affiliations:
  • Shenyang Pharmaceutical University, School of Pharmaceutical Engineering, MoE Key Laboratory of Structure-Based Drug Design & Discovery, China


According to our database1, Ying Wang authored at least 8 papers between 2018 and 2022.

Collaborative distances:
  • Dijkstra number2 of five.
  • Erdős number3 of four.

Timeline

Legend:

Book 
In proceedings 
Article 
PhD thesis 
Dataset
Other 

Links

Online presence:

On csauthors.net:

Bibliography

2022
Stepwise Strategy to Identify Thrombin as a Hydrolytic Substrate for Nattokinase.
J. Chem. Inf. Model., 2022

Stable H-bond networks are crucial for selective CDK4 inhibition revealed from comprehensive <i>in silico</i> investigation.
Comput. Biol. Chem., 2022

2020
Target recognition and network pharmacology for revealing anti-diabetes mechanisms of natural product.
J. Comput. Sci., 2020

Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
Comput. Biol. Chem., 2020

2019
In Silico Exploration of the Molecular Mechanism of Cassane Diterpenoids on Anti-inflammatory and Immunomodulatory Activity.
J. Chem. Inf. Model., 2019

Molecular determinants for ligand binding at Nav1.4 and Nav1.7 channels: Experimental affinity results analyzed by molecular modeling.
Comput. Biol. Chem., 2019

2018
In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations.
Comput. Biol. Chem., 2018

Computational insight into dengue virus NS2B-NS3 protease inhibition: A combined ligand- and structure-based approach.
Comput. Biol. Chem., 2018


  Loading...